Highlights of the University of Toronto Urology Update 2014

Overview

Journal Can Urol Assoc J

Specialty Urology

Date 2015 Mar 19

PMID 25784963

Authors

Sender Herschorn

Affiliations

Soon will be listed here.

Abstract

At the University of Toronto Urology Update 2014, a faculty of Canadian and American experts presented a series of lectures covering a range of topics in the field of urology. Areas of focus included prostate cancer (PCa), functional urology, erectile dysfunction (ED), and surgical topics (e.g., percutaneous nephrolithotomy [PCNL]).

References

Van Kerrebroeck P, Chapple C, Drogendijk T, Klaver M, Sokol R, Speakman M . Combination therapy with solifenacin and tamsulosin oral controlled absorption system in a single tablet for lower urinary tract symptoms in men: efficacy and safety results from the randomised controlled NEPTUNE trial. Eur Urol. 2013; 64(6):1003-12. DOI: 10.1016/j.eururo.2013.07.034. View

Dalkin B, Christopher B . Preservation of penile length after radical prostatectomy: early intervention with a vacuum erection device. Int J Impot Res. 2007; 19(5):501-4. DOI: 10.1038/sj.ijir.3901561. View

Liatsikos E, Hom D, Dinlenc C, Kapoor R, Alexianu M, Yohannes P . Tail stent versus re-entry tube: a randomized comparison after percutaneous stone extraction. Urology. 2002; 59(1):15-9. DOI: 10.1016/s0090-4295(01)01475-3. View

Montorsi F, Brock G, Lee J, Shapiro J, van Poppel H, Graefen M . Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol. 2008; 54(4):924-31. DOI: 10.1016/j.eururo.2008.06.083. View

Mohee A, Khan A, Harris N, Eardley I . Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB). BJU Int. 2012; 111(1):106-13. DOI: 10.1111/j.1464-410X.2012.11282.x. View

Montorsi F, Guazzoni G, Strambi L, Da Pozzo L, Nava L, Barbieri L . Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol. 1997; 158(4):1408-10. View

Kjellman A, Akre O, Norming U, Tornblom M, Gustafsson O . 15-year followup of a population based prostate cancer screening study. J Urol. 2009; 181(4):1615-21. DOI: 10.1016/j.juro.2008.11.115. View

Juul K, Klein B, Norgaard J . Long-term durability of the response to desmopressin in female and male nocturia patients. Neurourol Urodyn. 2012; 32(4):363-70. DOI: 10.1002/nau.22306. View

Nitti V, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C . OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol. 2012; 189(6):2186-93. DOI: 10.1016/j.juro.2012.12.022. View

10.

Metcalfe P, Cain M, Kaefer M, Gilley D, Meldrum K, Misseri R . What is the need for additional bladder surgery after bladder augmentation in childhood?. J Urol. 2006; 176(4 Pt 2):1801-5. DOI: 10.1016/j.juro.2006.03.126. View

11.

Cornu J, Abrams P, Chapple C, Dmochowski R, Lemack G, Michel M . A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis. Eur Urol. 2012; 62(5):877-90. DOI: 10.1016/j.eururo.2012.07.004. View

12.

Pietrow P, Auge B, Lallas C, Santa-Cruz R, Newman G, Albala D . Pain after percutaneous nephrolithotomy: impact of nephrostomy tube size. J Endourol. 2003; 17(6):411-4. DOI: 10.1089/089277903767923218. View

13.

Joshua A, Zannella V, Downes M, Bowes B, Hersey K, Koritzinsky M . A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancer. Prostate Cancer Prostatic Dis. 2014; 17(3):252-8. DOI: 10.1038/pcan.2014.20. View

14.

Bhindi B, Locke J, Alibhai S, Kulkarni G, Margel D, Hamilton R . Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort. Eur Urol. 2014; 67(1):64-70. DOI: 10.1016/j.eururo.2014.01.040. View

15.

De Sio M, Autorino R, Quattrone C, Giugliano F, Balsamo R, DArmiento M . Choosing the nephrostomy size after percutaneous nephrolithotomy. World J Urol. 2010; 29(6):707-11. DOI: 10.1007/s00345-010-0587-6. View

16.

Wang C, Lin Y, Huang S, Chang C . Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study. J Urol. 2010; 185(1):219-23. DOI: 10.1016/j.juro.2010.08.095. View

17.

Andriole G, Crawford E, Grubb 3rd R, Buys S, Chia D, Church T . Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009; 360(13):1310-9. PMC: 2944770. DOI: 10.1056/NEJMoa0810696. View

18.

Haffner J, Lemaitre L, Puech P, Haber G, Leroy X, Stephen Jones J . Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJU Int. 2011; 108(8 Pt 2):E171-8. DOI: 10.1111/j.1464-410X.2011.10112.x. View

19.

Hambrock T, Somford D, Hoeks C, Bouwense S, Huisman H, Yakar D . Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. J Urol. 2009; 183(2):520-7. DOI: 10.1016/j.juro.2009.10.022. View

20.

Izawa J, Klotz L, Siemens D, Kassouf W, So A, Jordan J . Prostate cancer screening: Canadian guidelines 2011. Can Urol Assoc J. 2011; 5(4):235-40. PMC: 3147035. DOI: 10.5489/cuaj.11134. View